Eli Lilly Issues Warning on Zepbound's Interaction with Vitamin B12

Eli Lilly has issued a warning regarding the potential risks associated with the active ingredient in Zepbound when combined with vitamin B12. Bloomberg posted on X, highlighting concerns that this interaction could pose health risks to patients. The pharmaceutical company advises healthcare providers and patients to be cautious and consult medical professionals before using these substances together. Eli Lilly's announcement underscores the importance of monitoring drug interactions to ensure patient safety. The company is committed to providing updates as more information becomes available.